Redigerer Oxford–AstraZeneca COVID-19-vaksine (avsnitt)

==Godkjennelser==
Vaksinen ble den 30. desember 2020 godkjent for bruk i Storbritannia,<ref>[https://www.bbc.com/news/health-55280671 ''Covid-19: Oxford-AstraZeneca coronavirus vaccine approved for use in UK'' på bbc.s nettsted den 30. desember 2020]</ref> og i [[Argentina]].<ref>[https://www.reuters.com/?url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-health-coronavirus-argentina-astrazen%2Fargentine-regulator-approves-astrazeneca-oxford-covid-19-vaccine-astrazeneca-idUSKBN29421P Reuters 30. desember 2020]</ref>, [[El Salvador]],<ref>{{cite news |last1=Staff |first1=Reuters |title=El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine |url=https://www.reuters.com/article/us-health-coronavirus-el-salvador-vaccin/el-salvador-greenlights-astrazeneca-oxford-university-covid-19-vaccine-idINKBN2942HQ |work=Reuters |date=30. desember 2020 }}</ref> og dagen etter i [[Den dominikanske republikk]]<ref>{{cite news |last1=Staff |first1=Agencia EFE |title=La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19 |url=https://www.efe.com/efe/america/sociedad/la-republica-dominicana-aprueba-vacuna-de-astrazeneca-contra-covid-19/20000013-4431079 |work=Agencia EFE |date=31. desember 2020 |language=es}}</ref>. Vaksinen ble den 29. januar godkjent av [[Det europeiske legemiddelbyrået]] for personer fra 18 års alder og oppover.<ref name="EMA recommendation">{{cite press release | title=EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU | website=[[European Medicines Agency]] (EMA) | date=29. januar 2021 | url=https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-astrazeneca-authorisation-eu | access-date=29. januar 2021}}</ref> Men i blant annet Norge ble den ikke godkjent for personer over 65 år.

Vaksinen, som går under navnet '''Covishield''' i India, ble godkjent av indiske myndigheter den 1. januar 2021.<ref>{{cite news |last1=Gaurav |first1=Kunal |title=Govt's expert panel approves AstraZeneca/Oxford Covid-19 vaccine for emergency use |url=https://www.hindustantimes.com/india-news/india-s-drug-regulator-approves-astrazeneca-oxford-vaccine-sources/story-qtnJQQTBI5vR6QGrXdoBzN.html |work=Hindustan Times |date=1. januar 2021 }}</ref><ref>{{cite news |last1=Jamkhandikar |first1=Nigam Prusty, Shilpa |title=India drug regulator approves AstraZeneca COVID vaccine, country's first - sources |url=https://in.reuters.com/article/health-coronavirus-india-vaccine-idINKBN296290 |work=Reuters |date=1. januar 2021 |accessdate=2021-01-08 |archivedate=2021-01-01 |archiveurl=https://web.archive.org/web/20210101224840/https://in.reuters.com/article/health-coronavirus-india-vaccine-idINKBN296290 |url-status=yes }}</ref><ref>[https://www.washingtonpost.com/world/asia_pacific/india-caccine-approval-oxford-serum-astrazeneca/2021/01/03/bea7d656-4aa3-11eb-97b6-4eb9f72ff46b_story.html ''India approves two vaccines as it prepares for massive immunization campaign'' i Washington Post 3. januar 2021]{{Død lenke|dato=juli 2021 |bot=InternetArchiveBot }}</ref>. Den 4. januar fulgte [[Bangladesh]]<ref>{{cite news |title=Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use |url=https://www.thedailystar.net/frontpage/news/oxford-university-astrazeneca-vaccine-bangladesh-okays-it-emergency-use-2022381 |access-date=7. januar 2021 |work=The Daily Star |date=4. januar 2021 }}</ref>, og 7. januar [[Mexico]]<ref>{{cite news |last1=Sanitarios |first1=Comisión Federal para la Protección contra Riesgos |title=AUTORIZACIÓN PARA USO DE EMERGENCIA A VACUNA ASTRAZENECA COVID-19 |url=https://www.gob.mx/cofepris/articulos/autorizacion-para-uso-de-emergencia-a-vacuna-astrazeneca-covid-19?idiom=es |access-date=7. januar 2021 |work=gob.mx |language=es}}</ref>.